Excelsior Biopharma Inc.
6496.TWO
Price:
$29.4
Market Cap:
$1.36B
Excelsior Biopharma Inc. develops and sells pharmaceutical products in Taiwan, China, and internationally. It offers prescription drugs, over-the-counter drugs, medical devices, healthcare food products, medical supplies, and other products. The company provides its products for the therapeutic areas, such as pediatrics, gastroenterology, neurology, cardiology, dermatology, medical toxicology, dentistry, obstetrics, oncology, hematology, and otorhinolaryngology, as well as infectious diseases. It also offers test kits under the Actim name to detect influenza virus, fecal occult blood, acute pancreatitis, preterm or full-week delivery, and early water breaking. In addition, the company provid...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2014-12-19
Stock Exchange
TWO
Ticker
6496.TWO
PE Ratio
[-8.19]
ROE
[-13.77%]
Current Ratio
[3.40]
Dividend Yield
[0%]
Enterprise Value
[1.62B]
Dividend History
The ROE as of December 2025 (TTM) for Excelsior Biopharma Inc. (6496.TWO) is -13.77%
According to Excelsior Biopharma Inc.’s latest financial reports and current stock price. The company's current ROE is -13.77%. This represents a change of 292.71% compared to the average of -3.51% of the last 4 quarters.
Excelsior Biopharma Inc. (6496.TWO) Historical ROE (quarterly & annually)
How has 6496.TWO ROE performed in the past?
The mean historical ROE of Excelsior Biopharma Inc. over the last ten years is -3.25%. The current -13.77% ROE has changed 323.50% with respect to the historical average. Over the past ten years (40 quarters), 6496.TWO's ROE was at its highest in in the December 2023 quarter at 0.57%. The ROE was at its lowest in in the June 2025 quarter at -5.34%.
Average
-3.25%
Median
-2.03%
Minimum
-9.96%
Maximum
2.75%
Excelsior Biopharma Inc. (6496.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of Excelsior Biopharma Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual ROE = 2.75%
Minimum Annual Increase = -146.24%
Minimum Annual ROE = -9.96%
| Year | ROE | Change |
|---|---|---|
| 2024 | -9.96% | 20.82% |
| 2023 | -8.24% | 194.75% |
| 2022 | -2.80% | 119.77% |
| 2021 | -1.27% | -146.24% |
| 2020 | 2.75% | Infinity% |
Excelsior Biopharma Inc. (6496.TWO) Average ROE
How has 6496.TWO ROE performed in the past?
The current ROE of Excelsior Biopharma Inc. (6496.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-7.00%
5-year avg
-3.90%
10-year avg
-3.25%
Excelsior Biopharma Inc. (6496.TWO) ROE vs. Peers
How is 6496.TWO’s ROE compared to its peers?
Excelsior Biopharma Inc.’s ROE is greater than Anxo Pharmaceutical Co., Ltd. (-4.18%), greater than Kim Forest Enterprise Co., Ltd. (-29.27%), greater than Holy Stone Healthcare Co., Ltd. (-51.30%), greater than GeneReach Biotechnology Corp. (-19.92%), greater than Unicon Optical Co., Ltd. (-47.77%), less than DV Biomed Co., Ltd. (0.24%), greater than MegaPro Biomedical Co., Ltd (-91.17%), greater than Tien Liang BioTech Co., Ltd. (-4.91%), greater than Prince Pharmaceutical Co., Ltd. (-1.50%), greater than Great Novel Therapeutics Biotech & Medicals (-14.66%),
| Company | ROE | Market cap |
|---|---|---|
| -4.18% | $1.21B | |
| -29.27% | $1.15B | |
| -51.30% | $1.29B | |
| -19.92% | $1.16B | |
| -47.77% | $1.15B | |
| 0.24% | $1.15B | |
| -91.17% | $994.05M | |
| -4.91% | $1.39B | |
| -1.50% | $1.12B | |
| -14.66% | $1.47B |
Build a custom stock screener for Excelsior Biopharma Inc. (6496.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Excelsior Biopharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Excelsior Biopharma Inc. (6496.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Excelsior Biopharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Excelsior Biopharma Inc.'s ROE?
How is the ROE calculated for Excelsior Biopharma Inc. (6496.TWO)?
What is the highest ROE for Excelsior Biopharma Inc. (6496.TWO)?
What is the 3-year average ROE for Excelsior Biopharma Inc. (6496.TWO)?
What is the 5-year average ROE for Excelsior Biopharma Inc. (6496.TWO)?
How does the current ROE for Excelsior Biopharma Inc. (6496.TWO) compare to its historical average?